Overview

Melatonin and the Metabolic Syndrome

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This trial seeks to compare the effects of melatonin supplementation versus placebo in subjects with the metabolic syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Treatments:
Melatonin